Advances in therapeutic cancer vaccines: harnessing immune adjuvants for enhanced efficacy and future perspectives
Article in Computational and Structural Biotechnology Journal (December 2024)
The most recent citing publications are shown below. View all 66 publications that cite this research output on Dimensions.
Orf virus as an adjuvant enhances the immune response to a PCV2 subunit vaccine
Article in Veterinary Microbiology (April 2024)
Applications of the partial-order continual reassessment method in the early development of treatment combinations.
Article in Clinical Trials (March 2024)